Previous findings have shown that in patients with rheumatoid arthritis (RA there is a higher than normal mean titer of antibody against a B-cell antigen (RANA) found only in lymphocytes infected by EBV, and that RA blood lymphocytes spontaneously yield in culture a high frequency of B cell clones carrying EBV DNA. We will examine the possibility that there is in RA a disorder involving an abnormal balance between endogenous EBV and its suppression by the immune system. Our studies will examine the characteristics of an 80,000 D EBV-related antigen detected in WI-L2 nuclear extracts with an anti-RANA serum and determine whether it corresponds to RANA immunologically. An attempt will be made to prepare a monoclonal antibody to it and develop an ELISA assay for both RANA and anti-RANA. With the ELISA assay we will determine the kinetics and quantity of RANA generated in normal and RA B lymphocytes. We will determine whether EBV-associated antigens are present in the tissues and fluids of patients with RA using a panel of EBV-related monoclonal antibodies and determine whether these antigens are incorporated into joint fluid or circulating rheumatoid factor (RF) complexes, either in solution or on the surface of leukocytes. Comparison with the normal autoantigens, DNA, Ia, RNP, and Sm will also be made. Serial studies will determine whether there is a variation in the amount of such antigen in RF complexes, that this is associated with variation in disease activity. To investigate the possibility of an abnormal regulation of the outgrowth of EBV-infected B cells, we will assay by limiting dilution the precursor frequencies of natural killer cells (NK) and HLA-restricted cytotoxic T lymphocytes (CTL), Interleukin-2 or interferon secreting cells directed against autologous EBV-infected B cells in normal and RA peripheral blood as compared to control subjects. In all these studies, a comparison will be made of the cells and tissues of control patients with other rheumatic disease or infectious mononucleosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR021175-10
Application #
3155157
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1977-12-01
Project End
1987-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
10
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92037
Handley, H H; Yu, J; Yu, D T et al. (1996) Autoantibodies to human heat shock protein (hsp)60 may be induced by Escherichia coli groEL. Clin Exp Immunol 103:429-35
Vaughan, J H; Nguyen, M D; Valbracht, J R et al. (1995) Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J Clin Invest 95:1316-27
Vaughan, J H; Valbracht, J R; Nguyen, M D et al. (1995) Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1. J Clin Invest 95:1306-15
Handley, H H; Ngyuen, M D; Yu, D T et al. (1995) Purification of recombinant human Hsp60: use of a GroEL-free preparation to assess autoimmunity in rheumatoid arthritis. J Autoimmun 8:659-73
Zuraw, B L; Lotz, M (1990) Regulation of the hepatic synthesis of C1 inhibitor by the hepatocyte stimulating factors interleukin 6 and interferon gamma. J Biol Chem 265:12664-70
Kouri, T; Petersen, J; Rhodes, G et al. (1990) Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. J Rheumatol 17:1442-9
Rhodes, G; Smith, R S; Rubin, R E et al. (1990) Identical IgM antibodies recognizing a glycine-alanine epitope are induced during acute infection with Epstein-Barr virus and cytomegalovirus. J Clin Lab Anal 4:456-64
Kouri, T; Crowley, J; Aho, K et al. (1990) Occurrence of two germline-related rheumatoid factor idiotypes in rheumatoid arthritis and in non-rheumatoid seropositive individuals. Clin Exp Immunol 82:250-6
Petersen, J; Rhodes, G; Roudier, J et al. (1990) Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 33:993-1000
Vaughan, J H (1989) Infection and autoimmunity. Curr Opin Immunol 1:708-17

Showing the most recent 10 out of 18 publications